Search Results
Found 2 results
510(k) Data Aggregation
(43 days)
SOLO-CARE PLUS Multipurpose Solution is indicated for cleaning, rinsing, chemical (not heat)disinfecting, daily protein removal, and storing of soft (hydrophilic) contact lenses (including silicone hydrogel lenses) as recommended by your eye care practitioner.
SOLO-Care Plus Multi-Purpose Solution is a sterile aqueous solution containing sodium chloride, bis-tris propane, pluronic F127. cremephor and preserved with edetate disodium dihydrate 0.025% and polyhexanide 0.0001%.
Here's a summary of the acceptance criteria and study information for the SOLO-Care Plus Multipurpose Solution, based on the provided text:
1. Table of Acceptance Criteria and Reported Device Performance
Study/Test Category | Acceptance Criteria | Reported Device Performance |
---|---|---|
Silicone Hydrogel Lens Compatibility | Meets the guidelines set forth in FDA's May 1, 1997 Guidance for Industry, Premarket Notification 510(k) Guidance Document for Contact Lens Care products (specifically, no significant difference from saline control in optical and physical changes). | The study showed no significant difference between SOLO-Care™ Plus Multi-Purpose Solution and the saline control solution with respect to optical and physical changes in the measured properties of Lotrafilcon A (silicone hydrogel) lenses. The device meets the specified FDA guidelines. |
In Vitro Cleaning Efficacy (Protein Removal) | Substantially equivalent to currently marketed SOLO-Care Multipurpose Solution. | SOLO-Care Plus was found to be substantially equivalent to SOLO-Care Multipurpose Solution in terms of daily protein removal. |
Cytotoxicity | Non-cytotoxic and non-irritant. | Testing demonstrated that SOLO-Care Multipurpose Solution (which SOLO-Care Plus is based on) is non-cytotoxic and a non-irritant. |
Microbiological Efficacy (Disinfection) | Meets "stand-alone criteria with organic load for disinfection" for both rub/rinse and pre-rinse/no rub regimens. Regimen test criteria also met for both regimens. | Both the rub/rinse and pre-rinse/no rub regimens demonstrated that SOLO-Care Multipurpose Solution met the stand-alone criteria with organic load for disinfection. The regimen test criteria were also met for both regimens for SOLO-Care Plus. |
Clinical Testing | To support substantial equivalency to a predicate device. | A series of clinical studies were conducted, submitted, and reviewed in the original 510(k) submission (K012731) to support the substantial equivalency of SOLO-Care Plus. The current submission concludes substantial equivalence based on this data. |
2. Sample Sizes Used for the Test Set and Data Provenance
The provided text does not explicitly state the sample sizes used for the test sets in the various studies (Silicone Hydrogel Lens Compatibility, In Vitro Cleaning Efficacy, Cytotoxicity, Microbiological, Clinical Testing).
The data provenance is retrospective for most tests. The document repeatedly states, "This data was previously submitted and reviewed in original 510(k) submission - K012731," indicating that the results from previous studies on the predicate device (SOLO-Care Multipurpose Solution) or an earlier version of SOLO-Care Plus were used to support the current submission. The Silicone Hydrogel Lens Compatibility study, however, appears to be a new study specific to the current submission ("A study was conducted to verify that Lotrafilcon A (silicone hydrogel) lenses are compatible with SOLO-Care Plus.").
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications
This information is not provided in the document. For an in vitro device like a contact lens solution, "ground truth" often refers to objective laboratory measurements (e.g., optical properties, protein levels, CFU counts, cell viability) rather than subjective expert assessment. Clinical "ground truth" would likely involve patient outcomes or assessments by eye care practitioners, but the specific details (number of experts, qualifications) are not given for the clinical studies mentioned.
4. Adjudication Method for the Test Set
This information is not provided in the document. As noted above, for laboratory-based tests, adjudication methods typical for image-based or diagnostic studies (like 2+1) are not usually applicable. For clinical studies, the document does not elaborate on how outcomes were assessed or discrepancies resolved.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was Done
No, an MRMC comparative effectiveness study is not mentioned or applicable in this context. The document pertains to a medical device (contact lens solution) and its performance through in vitro and clinical studies, not an AI diagnostic algorithm requiring human reader comparison.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Study was Done
No, a standalone algorithm study is not applicable here. This device is a chemical solution, not an algorithm. The performance described (compatibility, cleaning, cytotoxicity, disinfection) is the standalone performance of the solution itself.
7. The Type of Ground Truth Used
Based on the descriptions:
- Silicone Hydrogel Lens Compatibility: Objective physical and optical measurements of the lenses (e.g., as compared to a saline control).
- In Vitro Cleaning Efficacy: Measured protein removal levels.
- Cytotoxicity: Laboratory assays (e.g., cell viability, irritation scores) to determine non-cytotoxicity and non-irritancy.
- Microbiological Efficacy: Quantitative microbial counts (e.g., Colony Forming Units - CFU) to demonstrate disinfection efficacy against specific microorganisms, compared to established "stand-alone criteria."
- Clinical Testing: Not explicitly detailed, but would likely involve clinical endpoints related to lens wear comfort, ocular health, and adverse events as assessed by eye care practitioners or reported by patients, used to establish substantial equivalence.
8. The Sample Size for the Training Set
This information is not applicable or provided. This device is a chemical solution, not an AI algorithm that requires a "training set." The studies described involve testing the solution's properties, not training a model.
9. How the Ground Truth for the Training Set was Established
This information is not applicable for the same reasons as #8.
Ask a specific question about this device
(133 days)
SOLO-Care™ Plus Multi-Purpose Solution is indicated for cleaning, rinsing, chemical (not heat) disinfecting, protein removal, and storing soft (hydrophilic), rigid gas permeable (fluoro silicon acrylate and silicon acrylate) contact lenses as recommended by your eye care practitioner.
SOLO-Care Plus Multi-Purpose Solution is a sterile aqueous solution containing sodium chloride, SOLO-Gare Plus Mulli Purpood Solution and preserved with edetate disodium dihydrate 0.025% and polyhexanide 0.0001%.
Here's a breakdown of the acceptance criteria and the studies conducted to demonstrate the substantial equivalence of SOLO-Care Plus Multipurpose Solution, based on the provided 510(k) summary:
1. Table of Acceptance Criteria and Reported Device Performance
The document doesn't explicitly define numerical "acceptance criteria" in the way one might see for diagnostic accuracy. Instead, the acceptance criteria are implicitly framed as "substantial equivalence" to predicate devices, meaning the new device performs at least as well or doesn't show significant negative differences across various safety and efficacy measures.
Category | Acceptance Criteria (Implicit) | Reported Device Performance |
---|---|---|
Lens Compatibility | No significant difference in physical/optical properties compared to predicate devices. | "No significant difference between SOLO-Care™ Plus Multi-Purpose Solution and the predicate device... no significant optical and physical changes in the measured properties of the lenses." |
Safe, biocompatible, and comparable to other marketed solutions. | "Results was conduction in accordance with and in conformance to applicable device regulations. Results demonstrated that SOLO-Care Plus is safe and biocompatible, and is comparable to other currently marketed soft contact lens solutions." | |
Cleaning Efficacy | Substantially equivalent protein cleaning efficacy to predicate device. | "SOLOCare Plus is substantially equivalent to SOLO-Care Multipurpose Solution in terms of daily protein removal." |
Cytotoxicity | Non-cytotoxic and non-irritant. | "SOLO-Care Multipurpose Solution is non-cytotoxic and is a non-irritant." |
Microbiological | Meet regiment test criteria for microbial efficacy under rub/rinse and pre-rinse regimens. | "Both regimen demonstrated that SOLO-Care Multipurpose [sic] no rub regimen. The no [sic] also disinfection. Additionally, the regiment test criteria was also meet for both regimen for SOLO-Care Plus." (Suggests criteria were met for both rub/rinse and pre-rinse protocols based on substantial equivalence.) |
Clinical Safety/Comfort (Study #1) | Acceptable for proceeding to validation study; low safety variables; high comfort; low acceptable subjective complaints; substantially equivalent to predicate. | "SOLO-Care Plus was found to be an effective multipurpose solution... safety variables were low with little difference between the test solution and the control. Comfort levels were high at all times, and the subjective complaints were low in number and acceptable... substantially equivalent to SOLO-Care Multipurpose Solution." |
Clinical Safety/Effectiveness (Study #2) | Safe and effective; substantially equivalent to predicate. | "SOLO-Care Plus was found safe and effective multipurpose solution for soft contact lenses and was found to be substantially equivalent to SOLOCare Multipurpose Solution." |
Clinical Non-inferiority (Study #3) | Non-inferior to predicate using a no-rub regimen. | "The data in this clinical trial was consistent in showing substantial equivalence between SOLO-Care Plus without a rub and rinse versus Comfortplus Multipurpose Solution with a pre and post rinse with overnight soaking." |
2. Sample Sizes and Data Provenance
In-Vitro/Preclinical Studies:
- Lens Compatibility Data: Not specified.
- In Vitro Cleaning Efficacy: Not specified.
- Cytotoxicity: Not specified.
- Microbiological Studies: Not specified.
- Data Provenance: Implied to be from CIBA Vision Corporation's internal testing facilities (likely US-based) and conducted to applicable device regulations. Retrospective or prospective nature not explicitly stated, but typically these in-vitro tests are prospective.
Clinical Studies:
- Study #1: 15 subjects. Prospective, randomized, investigator masked, contralateral study. Likely conducted in the US based on the submitting company's location and FDA submission.
- Study #2: 95 subjects. Prospective, investigator masked, contralateral study. Likely conducted in the US.
- Study #3: 73 subjects. Prospective, randomized, investigator masked, contralateral study. Conducted in the UK ("BTP Crème versus Complete U.K. Clinical Trial").
3. Number and Qualifications of Experts for Ground Truth
For preclinical (in-vitro) studies, the "ground truth" is typically established through laboratory methodologies and internal quality control, not external expert consensus as would be seen for imaging diagnostics. The report doesn't specify an "expert" panel for these.
For clinical studies, the "ground truth" is generally patient-reported outcomes (comfort, subjective complaints) and investigator-assessed safety variables (e.g., ocular health parameters).
- Number of experts: Not explicitly stated as a separate ground-truth panel. However, the studies involved "investigators" who performed assessments.
- Qualifications of experts: Not specified beyond being "investigator masked." Given the nature of contact lens studies, these would typically be ophthalmologists, optometrists, or trained clinical researchers. Study #2 mentions "five investigator," implying five clinical sites or primary investigators.
4. Adjudication Method for the Test Set
- Preclinical (in-vitro) studies: Not applicable in the sense of expert adjudication. Results are based on direct measurement and established laboratory protocols.
- Clinical studies: The studies were "investigator masked" and "contralateral," meaning subjects used both the test and control solutions, and the investigator was unaware which eye received which solution until unmasking. This design intrinsically reduces bias. There is no mention of an independent adjudication committee for clinical endpoints beyond the assessing investigators themselves.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
No, an MRMC comparative effectiveness study was not done. This type of study is typically associated with diagnostic imaging devices where multiple readers interpret cases to assess accuracy in comparison to a gold standard. The device here is a contact lens solution, and the studies focused on safety, comfort, and efficacy (cleaning, disinfection) rather than diagnostic interpretation. Therefore, measurements like "effect size of how much human readers improve with AI vs without AI assistance" are not relevant to this submission.
6. Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study
Not applicable. This device is a contact lens solution, not an AI algorithm. The performance of the solution is assessed directly, sometimes with human "in-the-loop" performance in terms of patient use and investigator assessment (clinical studies), but not in the context of an algorithm's standalone performance.
7. Type of Ground Truth Used
- Preclinical (in-vitro) ground truth:
- Lens Compatibility: Laboratory measurements of physical and optical lens properties.
- In Vitro Cleaning Efficacy: Quantification of protein removal (laboratory assay).
- Cytotoxicity: Standardized cell culture assays for toxicity and irritation.
- Microbiological: Standardized microbiological challenge tests and culture methods to assess disinfection efficacy.
- Clinical (in-vivo) ground truth:
- Patient-reported outcomes: Subjective complaints, comfort levels.
- Investigator assessments: Ocular safety variables, clinical observations related to eye health and contact lens wear.
- Comparison to predicate device: The ground truth for proving substantial equivalence often relies on demonstrating non-inferiority or similar performance to an already accepted predicate device.
8. Sample Size for the Training Set
Not applicable. This device is a chemical solution, not an AI algorithm. Therefore, there is no "training set" in the context of machine learning. The term "training set" is not relevant here.
9. How the Ground Truth for the Training Set Was Established
Not applicable, as there is no training set for this type of medical device.
Ask a specific question about this device
Page 1 of 1